← Browse by Condition
Medical Condition

subjects with mild hypertension

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07117474 Phase 1
Recruiting

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Subcutaneous Injection of HRS-9563 in Subjects With Mild Hypertension: a Randomized, Double-blind, Placebo-controlled Phase I Study.

Enrollment
60 pts
Location
China
Sponsor
Fujian Shengdi Pharmaceutical ...
View Trial →